Engineering bone: challenges and obstacles
暂无分享,去创建一个
[1] V. Bousson,et al. De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. , 2005, Tissue engineering.
[2] Frédéric Chaubet,et al. Retention of transforming growth factor beta1 using functionalized dextran-based hydrogels. , 2005, Biomaterials.
[3] R. Löbenberg,et al. Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates. , 2004, Journal of Controlled Release.
[4] Rui L Reis,et al. Bone tissue engineering: state of the art and future trends. , 2004, Macromolecular bioscience.
[5] Andrés J. García,et al. α2β1 integrin‐specific collagen‐mimetic surfaces supporting osteoblastic differentiation , 2004 .
[6] A. Flake,et al. Mesenchymal stem cells: paradoxes of passaging. , 2004, Experimental hematology.
[7] Christopher H Contag,et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects , 2004, Nature Biotechnology.
[8] F. Barry,et al. Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.
[9] J. Fisher,et al. Effect of biomaterial properties on bone healing in a rabbit tooth extraction socket model. , 2004, Journal of biomedical materials research. Part A.
[10] W. Otto,et al. Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage , 2004, Cell proliferation.
[11] D. Wendt,et al. The role of bioreactors in tissue engineering. , 2004, Trends in biotechnology.
[12] F. Djouad,et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. , 2003, Blood.
[13] Antonios G Mikos,et al. Biomimetic materials for tissue engineering. , 2003, Biomaterials.
[14] J. Davies,et al. Use of a biomimetic strategy to engineer bone. , 2003, Journal of biomedical materials research. Part A.
[15] K. Leong,et al. Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. , 2003, Biomaterials.
[16] A J Verbout,et al. Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. , 2003, Tissue engineering.
[17] E. Guinan,et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation , 2003, Transplantation.
[18] O. Ringdén,et al. Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.
[19] H. Petite,et al. Marrow Stromal Stem Cells for Repairing the Skeleton , 2002, Biotechnology & genetic engineering reviews.
[20] H. Jennissen,et al. Accelerated and Improved Osteointegration of Implants Biocoated with Bone Morphogenetic Protein 2 (BMP‐2) , 2002, Annals of the New York Academy of Sciences.
[21] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[22] J. Wozney,et al. Delivering on the promise of bone morphogenetic proteins. , 2001, Trends in biotechnology.
[23] J. Wozney,et al. Delivery Systems for BMPs: Factors Contributing to Protein Retention at an Application Site , 2001, The Journal of bone and joint surgery. American volume.
[24] David J. Mooney,et al. Promoting Angiogenesis in Engineered Tissues , 2001, Journal of drug targeting.
[25] J Bonadio,et al. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. , 2000, Advanced drug delivery reviews.
[26] C. Kirker-Head,et al. Potential applications and delivery strategies for bone morphogenetic proteins. , 2000, Advanced drug delivery reviews.
[27] T. Kohgo,et al. Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation. , 2000, Journal of Biomedical Materials Research.
[28] J. Hubbell,et al. Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[29] A Boyde,et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. , 2000, Journal of biomedical materials research.
[30] E. Shors. Coralline bone graft substitutes. , 1999, The Orthopedic clinics of North America.
[31] P. Schiller,et al. Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] K E Healy,et al. Designing Biomaterials to Direct Biological Responses , 1999, Annals of the New York Academy of Sciences.
[33] V. Goldberg,et al. The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.
[34] R. Bizios,et al. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. , 1998, Journal of biomedical materials research.
[35] W. Hayes,et al. Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[36] H. Ohgushi,et al. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. , 1998, Journal of biomedical materials research.
[37] M J Yaszemski,et al. Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. , 1997, Journal of biomedical materials research.
[38] R. Midura,et al. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[39] S. Kadiyala,et al. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect , 1997 .
[40] D. Rowe,et al. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. , 1997, Transplantation.
[41] S. Bruder,et al. Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.
[42] S. Bruder,et al. Growth kinetics, self‐renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation , 1997, Journal of cellular biochemistry.
[43] C. Colton,et al. Implantable biohybrid artificial organs. , 1995, Cell transplantation.
[44] Jeffrey A. Hubbell,et al. Biomaterials in Tissue Engineering , 1995, Bio/Technology.
[45] T A Einhorn,et al. Enhancement of fracture-healing. , 1995, The Journal of bone and joint surgery. American volume.
[46] Robert Langer,et al. Preparation and characterization of poly(l-lactic acid) foams , 1994 .
[47] A. Reddi,et al. The critical role of geometry of porous hydroxyapatite delivery system in induction of bone by osteogenin, a bone morphogenetic protein. , 1992, Matrix.
[48] S. Furner,et al. Musculoskeletal Conditions in the United States , 1992 .
[49] C J Damien,et al. Bone graft and bone graft substitutes: a review of current technology and applications. , 1991, Journal of applied biomaterials : an official journal of the Society for Biomaterials.
[50] V. Goldberg,et al. Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic. , 1991, Biomaterials.
[51] P. Iványi,et al. H-2-dependent binding of xenogeneic beta 2-microglobulin from culture media. , 1988, Journal of immunology.
[52] C. Joyner,et al. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. , 1987, Journal of cell science.
[53] H. Gabbert,et al. Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. , 1986, Cancer research.
[54] A. Reddi,et al. Importance of geometry of the extracellular matrix in endochondral bone differentiation , 1984, The Journal of cell biology.
[55] MacDermott Rp,et al. Fetal calf serum augmentation during cell separation procedures accounts for the majority of human autologous mixed leukocyte reactivity. , 1983 .
[56] J. Folkman,et al. SELF-REGULATION OF GROWTH IN THREE DIMENSIONS , 1973, The Journal of experimental medicine.
[57] A. Friedenstein,et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.
[58] Andrés J. García,et al. Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation. , 2004, Journal of biomedical materials research. Part A.
[59] Kevin McIntosh,et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.
[60] A I Caplan,et al. Stem cell technology and bioceramics: from cell to gene engineering. , 1999, Journal of biomedical materials research.
[61] K E Healy,et al. Biomimetic Peptide Surfaces That Regulate Adhesion, Spreading, Cytoskeletal Organization, and Mineralization of the Matrix Deposited by Osteoblast‐like Cells , 1999, Biotechnology progress.
[62] J. A. Cooper,et al. Tissue engineering: orthopedic applications. , 1999, Annual review of biomedical engineering.
[63] N. Endo,et al. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation , 1999, Journal of Bone and Mineral Metabolism.
[64] J. Wozney. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. , 1998, European journal of oral sciences.
[65] B D Boyan,et al. Role of material surfaces in regulating bone and cartilage cell response. , 1996, Biomaterials.
[66] A I Caplan,et al. Characterization of cells with osteogenic potential from human marrow. , 1992, Bone.
[67] R. Macdermott,et al. Fetal calf serum augmentation during cell separation procedures accounts for the majority of human autologous mixed leukocyte reactivity. , 1983, Behring Institute Mitteilungen.